Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ABCA4 CL E G H | 24 | 34 | ORPHA:827 | Stargardt disease | | | | 826 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ABCB6 CL E G H | 10058 | 47 | OMIM:614497 | Microphthalmia, isolated, with coloboma 7 | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ACTB CL E G H | 60 | 132 | OMIM:243310 | Baraitser-Winter syndrome 1 | | | | 72 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ACTG1 CL E G H | 71 | 144 | OMIM:614583 | Baraitser-Winter syndrome 2 | | | | 123 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ADAMTS10 CL E G H | 81794 | 13201 | OMIM:277600 | Weill-Marchesani syndrome 1 | | | | 63 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ADAMTSL1 CL E G H | 92949 | 14632 | ORPHA:521445 | Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALDH1A2 CL E G H | 8854 | 15472 | OMIM:620025 | | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALDH1A3 CL E G H | 220 | 409 | OMIM:615113 | Microphthalmia, isolated 8 | | | | 10 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALDH1A3 CL E G H | 220 | 409 | ORPHA:35612 | Nanophthalmos | | | | 10 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALDH6A1 CL E G H | 4329 | 7179 | OMIM:614105 | Methylmalonate semialdehyde dehydrogenase deficiency | | | | 35 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALX1 CL E G H | 8092 | 1494 | OMIM:613456 | Frontonasal dysplasia 3 | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALX1 CL E G H | 8092 | 1494 | ORPHA:306542 | Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALX3 CL E G H | 257 | 449 | OMIM:136760 | Frontonasal dysplasia 1 | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALX3 CL E G H | 257 | 449 | ORPHA:391474 | Frontorhiny | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALX4 CL E G H | 60529 | 450 | OMIM:613451 | Frontonasal dysplasia 2 | | | | 132 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ALX4 CL E G H | 60529 | 450 | ORPHA:228390 | Frontonasal dysplasia-alopecia-genital anomalies syndrome | | | | 132 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ANKRD11 CL E G H | 29123 | 21316 | ORPHA:261250 | 16q24.3 microdeletion syndrome | | | | 102 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | AP2M1 CL E G H | 1173 | 564 | ORPHA:1942 | Myoclonic-astatic epilepsy | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | AP3D1 CL E G H | 8943 | 568 | ORPHA:54 | X-linked recessive ocular albinism | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | APC CL E G H | 324 | 583 | ORPHA:261584 | Familial adenomatous polyposis due to 5q22.2 microdeletion | | | | 3179 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ARHGAP31 CL E G H | 57514 | 29216 | ORPHA:974 | Adams-Oliver syndrome | | | | 147 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ARHGAP31 CL E G H | 57514 | 29216 | OMIM:100300 | Adams-Oliver syndrome 1 | | | | 147 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ARNT2 CL E G H | 9915 | 16876 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ARSL CL E G H | 415 | 719 | ORPHA:79345 | Brachytelephalangic chondrodysplasia punctata | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ARX CL E G H | 170302 | 18060 | OMIM:308350 | Developmental and epileptic encephalopathy 1 | | | | 166 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ASPH CL E G H | 444 | 757 | OMIM:601552 | Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ATAD3A CL E G H | 55210 | 25567 | ORPHA:496790 | Ocular anomalies-axonal neuropathy-developmental delay syndrome | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ATF6 CL E G H | 22926 | 791 | ORPHA:49382 | Achromatopsia | | | | 10 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ATF6 CL E G H | 22926 | 791 | OMIM:616517 | ACHROMATOPSIA 7; ACHM7 | | | | 10 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ATN1 CL E G H | 1822 | 3033 | OMIM:618494 | Congenital hypotonia, epilepsy, developmental delay, and digital anomalies | | | | 16 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ATOH7 CL E G H | 220202 | 13907 | ORPHA:91495 | Persistent hyperplastic primary vitreous | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ATOH7 CL E G H | 220202 | 13907 | OMIM:221900 | Persistent hyperplastic primary vitreous, autosomal recessive | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | B3GALNT2 CL E G H | 148789 | 28596 | OMIM:615181 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | B3GALNT2 CL E G H | 148789 | 28596 | ORPHA:899 | Walker-Warburg syndrome | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | B4GAT1 CL E G H | 11041 | 15685 | ORPHA:899 | Walker-Warburg syndrome | | | | 17 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | B9D1 CL E G H | 27077 | 24123 | ORPHA:564 | Meckel syndrome | | | | 28 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | B9D2 CL E G H | 80776 | 28636 | ORPHA:564 | Meckel syndrome | | | | 34 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BAZ1B CL E G H | 9031 | 961 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BCL7B CL E G H | 9275 | 1005 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BCOR CL E G H | 54880 | 20893 | ORPHA:568 | Microphthalmia, Lenz type | | | | 101 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BCOR CL E G H | 54880 | 20893 | OMIM:309800 | Microphthalmia, syndromic 1 | | | | 101 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BCOR CL E G H | 54880 | 20893 | OMIM:300166 | Microphthalmia, syndromic 2 | | | | 101 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BCOR CL E G H | 54880 | 20893 | ORPHA:2712 | Oculofaciocardiodental syndrome | | | | 101 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BDNF CL E G H | 627 | 1033 | ORPHA:893 | WAGR syndrome | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BEST1 CL E G H | 7439 | 12703 | ORPHA:35612 | Nanophthalmos | | | | 182 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BEST1 CL E G H | 7439 | 12703 | OMIM:193220 | VITREORETINOCHOROIDOPATHY | | | | 182 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BLOC1S3 CL E G H | 388552 | 20914 | OMIM:614077 | Hermansky-Pudlak syndrome 8 | | | | 42 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BLOC1S5 CL E G H | 63915 | 18561 | OMIM:619172 | HERMANSKY-PUDLAK SYNDROME 11; HPS11 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BMP4 CL E G H | 652 | 1071 | ORPHA:139471 | Microphthalmia with brain and digit anomalies | | | | 38 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BMP4 CL E G H | 652 | 1071 | OMIM:607932 | Microphthalmia, syndromic 6 | | | | 38 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BRCA1 CL E G H | 672 | 1100 | ORPHA:84 | Fanconi anemia | | | | 5769 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BRCA1 CL E G H | 672 | 1100 | OMIM:617883 | Fanconi anemia, complementation group S | | | | 5769 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BRCA2 CL E G H | 675 | 1101 | ORPHA:84 | Fanconi anemia | | | | 7642 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BRCA2 CL E G H | 675 | 1101 | ORPHA:654 | Nephroblastoma | | | | 7642 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BRIP1 CL E G H | 83990 | 20473 | ORPHA:84 | Fanconi anemia | | | | 1086 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BRIP1 CL E G H | 83990 | 20473 | OMIM:609054 | FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ | | | | 1086 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BTRC CL E G H | 8945 | 1144 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BUB1 CL E G H | 699 | 1148 | ORPHA:1052 | Mosaic variegated aneuploidy syndrome | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BUB1B CL E G H | 701 | 1149 | ORPHA:1052 | Mosaic variegated aneuploidy syndrome | | | | 76 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BUB3 CL E G H | 9184 | 1151 | ORPHA:1052 | Mosaic variegated aneuploidy syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | BUD23 CL E G H | 114049 | 16405 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | C12ORF57 CL E G H | 113246 | 29521 | ORPHA:1777 | Temtamy syndrome | | | | 13 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CACNA1C CL E G H | 775 | 1390 | OMIM:620029 | | | | | 572 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CACNA1F CL E G H | 778 | 1393 | OMIM:300600 | Aland island eye disease | | | | 58 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CACNA1F CL E G H | 778 | 1393 | ORPHA:178333 | Ã…land Islands eye disease | | | | 58 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CAPN15 CL E G H | 6650 | 11182 | OMIM:619318 | OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME; OGIN | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CARS1 CL E G H | 833 | 1493 | ORPHA:33364 | Trichothiodystrophy | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CASK CL E G H | 8573 | 1497 | OMIM:300749 | Mental retardation and microcephaly with pontine and cerebellar hypoplasia | | | | 118 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CASK CL E G H | 8573 | 1497 | ORPHA:163937 | X-linked intellectual disability, Najm type | | | | 118 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CC2D2A CL E G H | 57545 | 29253 | ORPHA:564 | Meckel syndrome | | | | 247 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CDC42BPB CL E G H | 9578 | 1738 | OMIM:619841 | | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:95496 | Pituitary stalk interruption syndrome | | | | 200 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CENPF CL E G H | 1063 | 1857 | OMIM:243605 | Stromme syndrome | | | | 27 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CEP120 CL E G H | 153241 | 26690 | OMIM:616300 | Short-Rib thoracic dysplasia 13 with or without polydactyly | | | | 7 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CEP290 CL E G H | 80184 | 29021 | ORPHA:564 | Meckel syndrome | | | | 342 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CEP290 CL E G H | 80184 | 29021 | OMIM:611134 | Meckel syndrome, type 4 | | | | 342 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CEP57 CL E G H | 9702 | 30794 | ORPHA:1052 | Mosaic variegated aneuploidy syndrome | | | | 17 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CEP85L CL E G H | 387119 | 21638 | ORPHA:572013 | Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CFAP418 CL E G H | 157657 | 27232 | OMIM:617406 | Bardet-Biedl syndrome 21 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CHD2 CL E G H | 1106 | 1917 | ORPHA:1942 | Myoclonic-astatic epilepsy | | | | 227 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CHD7 CL E G H | 55636 | 20626 | ORPHA:138 | CHARGE syndrome | | | | 515 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CHD7 CL E G H | 55636 | 20626 | OMIM:214800 | Charge syndrome | | | | 515 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CHN1 CL E G H | 1123 | 1943 | ORPHA:233 | Duane retraction syndrome | | | | 35 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CHUK CL E G H | 1147 | 1974 | OMIM:619339 | BARTSOCAS-PAPAS SYNDROME 2; BPS2 | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CLIP2 CL E G H | 7461 | 2586 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CNGA3 CL E G H | 1261 | 2150 | ORPHA:49382 | Achromatopsia | | | | 82 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CNGA3 CL E G H | 1261 | 2150 | OMIM:216900 | Achromatopsia 2 | | | | 82 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CNGB3 CL E G H | 54714 | 2153 | ORPHA:49382 | Achromatopsia | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CNGB3 CL E G H | 54714 | 2153 | ORPHA:827 | Stargardt disease | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COL18A1 CL E G H | 80781 | 2195 | OMIM:267750 | Knobloch syndrome 1 | | | | 177 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COL2A1 CL E G H | 1280 | 2200 | ORPHA:485 | Kniest dysplasia | | | | 284 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COL4A1 CL E G H | 1282 | 2202 | OMIM:175780 | Brain small vessel disease 1 with or without ocular anomalies | | | | 193 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COL4A1 CL E G H | 1282 | 2202 | ORPHA:899 | Walker-Warburg syndrome | | | | 193 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 6 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COX14 CL E G H | 84987 | 28216 | OMIM:619053 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10; MC4DN10 | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COX7B CL E G H | 1349 | 2291 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 6 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | COX7B CL E G H | 1349 | 2291 | OMIM:309801 | Microphthalmia, syndromic 7 | | | | 6 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CPAMD8 CL E G H | 27151 | 23228 | OMIM:617319 | Anterior segment dysgenesis 8 | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CPLX1 CL E G H | 10815 | 2309 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CRB1 CL E G H | 23418 | 2343 | ORPHA:35612 | Nanophthalmos | | | | 156 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CRPPA CL E G H | 729920 | 37276 | OMIM:614643 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CRPPA CL E G H | 729920 | 37276 | ORPHA:899 | Walker-Warburg syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CRYAA CL E G H | 1409 | 2388 | OMIM:604219 | Cataract 9, multiple types | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CSPP1 CL E G H | 79848 | 26193 | OMIM:615636 | Joubert syndrome 21 | | | | 57 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CSPP1 CL E G H | 79848 | 26193 | ORPHA:564 | Meckel syndrome | | | | 57 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CTBP1 CL E G H | 1487 | 2494 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CTDP1 CL E G H | 9150 | 2498 | ORPHA:48431 | Congenital cataracts-facial dysmorphism-neuropathy syndrome | | | | 17 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 88 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | CYTB CL E G H | 4519 | 7427 | ORPHA:137675 | Histiocytoid cardiomyopathy | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DACT1 CL E G H | 51339 | 17748 | ORPHA:857 | Townes-Brocks syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DAG1 CL E G H | 1605 | 2666 | OMIM:616538 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9 | | | | 108 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DAG1 CL E G H | 1605 | 2666 | ORPHA:899 | Walker-Warburg syndrome | | | | 108 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DCT CL E G H | 1638 | 2709 | OMIM:619165 | OCULOCUTANEOUS ALBINISM, TYPE VIII; OCA8 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DDHD2 CL E G H | 23259 | 29106 | ORPHA:320380 | Autosomal recessive spastic paraplegia type 54 | | | | 29 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DDHD2 CL E G H | 23259 | 29106 | OMIM:615033 | Spastic paraplegia 54, autosomal recessive | | | | 29 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DHCR7 CL E G H | 1717 | 2860 | ORPHA:818 | Smith-Lemli-Opitz syndrome | HP:0040283 - Occasional | | | 159 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DIS3L2 CL E G H | 129563 | 28648 | ORPHA:654 | Nephroblastoma | | | | 164 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DLL4 CL E G H | 54567 | 2910 | ORPHA:974 | Adams-Oliver syndrome | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DLST CL E G H | 1743 | 2911 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DLX5 CL E G H | 1749 | 2918 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DLX6 CL E G H | 1750 | 2919 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DNAJC30 CL E G H | 84277 | 16410 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DNMT3A CL E G H | 1788 | 2978 | OMIM:615879 | Tatton-Brown-Rahman syndrome | | | | 44 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DOCK6 CL E G H | 57572 | 19189 | ORPHA:974 | Adams-Oliver syndrome | | | | 18 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DOCK6 CL E G H | 57572 | 19189 | OMIM:614219 | Adams-Oliver syndrome 2 | | | | 18 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DOCK7 CL E G H | 85440 | 19190 | ORPHA:411986 | Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DONSON CL E G H | 29980 | 2993 | OMIM:251230 | Microcephaly-Micromelia syndrome | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DPYD CL E G H | 1806 | 3012 | ORPHA:1675 | Dihydropyrimidine dehydrogenase deficiency | | | | 144 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | DPYD CL E G H | 1806 | 3012 | OMIM:274270 | Dihydropyrimidine dehydrogenase deficiency | | | | 144 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EBP CL E G H | 10682 | 3133 | OMIM:302960 | Chondrodysplasia punctata 2, X-linked dominant | | | | 51 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EBP CL E G H | 10682 | 3133 | ORPHA:401973 | MEND syndrome | | | | 51 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EBP CL E G H | 10682 | 3133 | ORPHA:35173 | X-linked dominant chondrodysplasia punctata | | | | 51 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EIF4H CL E G H | 7458 | 12741 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ELN CL E G H | 2006 | 3327 | ORPHA:904 | Williams syndrome | | | | 172 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ELOVL4 CL E G H | 6785 | 14415 | ORPHA:827 | Stargardt disease | | | | 62 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ELP4 CL E G H | 26610 | 1171 | OMIM:617141 | Aniridia 2 | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EOGT CL E G H | 285203 | 28526 | ORPHA:974 | Adams-Oliver syndrome | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EPG5 CL E G H | 57724 | 29331 | OMIM:242840 | Vici syndrome | | | | 40 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EPS15L1 CL E G H | 58513 | 24634 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC1 CL E G H | 2067 | 3433 | OMIM:610758 | Cerebrooculofacioskeletal syndrome 4 | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC1 CL E G H | 2067 | 3433 | ORPHA:90322 | Cockayne syndrome type 2 | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC1 CL E G H | 2067 | 3433 | ORPHA:1466 | COFS syndrome | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC2 CL E G H | 2068 | 3434 | OMIM:610756 | Cerebrooculofacioskeletal syndrome 2 | | | | 106 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:1466 | COFS syndrome | | | | 106 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:33364 | Trichothiodystrophy | | | | 106 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC2 CL E G H | 2068 | 3434 | OMIM:601675 | Trichothiodystrophy 1, photosensitive | | | | 106 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC2 CL E G H | 2068 | 3434 | OMIM:278730 | Xeroderma pigmentosum, complementation group D | | | | 106 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:33364 | Trichothiodystrophy | | | | 54 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC3 CL E G H | 2071 | 3435 | OMIM:610651 | Xeroderma pigmentosum, complementation group B | | | | 54 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:90321 | Cockayne syndrome type 1 | | | | 158 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:84 | Fanconi anemia | | | | 158 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC5 CL E G H | 2073 | 3437 | OMIM:616570 | Cerebrooculofacioskeletal syndrome 3 | | | | 83 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:1466 | COFS syndrome | | | | 83 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC5 CL E G H | 2073 | 3437 | OMIM:278780 | Xeroderma pigmentosum, complementation group G | | | | 83 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:214150 | Cerebrooculofacioskeletal syndrome 1 | | | | 199 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC6 CL E G H | 2074 | 3438 | ORPHA:90321 | Cockayne syndrome type 1 | | | | 199 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC6 CL E G H | 2074 | 3438 | ORPHA:90322 | Cockayne syndrome type 2 | | | | 199 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC6 CL E G H | 2074 | 3438 | ORPHA:90324 | Cockayne syndrome type 3 | | | | 199 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:133540 | Cockayne syndrome, type B | | | | 199 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC6 CL E G H | 2074 | 3438 | ORPHA:1466 | COFS syndrome | | | | 199 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC8 CL E G H | 1161 | 3439 | ORPHA:90321 | Cockayne syndrome type 1 | | | | 55 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC8 CL E G H | 1161 | 3439 | ORPHA:90322 | Cockayne syndrome type 2 | | | | 55 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERCC8 CL E G H | 1161 | 3439 | ORPHA:90324 | Cockayne syndrome type 3 | | | | 55 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ERF CL E G H | 2077 | 3444 | OMIM:600775 | Craniosynostosis 4 | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ESCO2 CL E G H | 157570 | 27230 | OMIM:268300 | Roberts syndrome | | | | 92 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ESCO2 CL E G H | 157570 | 27230 | ORPHA:3103 | Roberts syndrome | | | | 92 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | EXOC2 CL E G H | 55770 | 24968 | OMIM:619306 | NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND CEREBELLAR HYPOPLASIA; NEDFACH | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FAM111A CL E G H | 63901 | 24725 | ORPHA:93325 | Autosomal dominant Kenny-Caffey syndrome | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FAM111A CL E G H | 63901 | 24725 | OMIM:602361 | Gracile bone dysplasia | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FAM111A CL E G H | 63901 | 24725 | OMIM:127000 | Kenny-caffey syndrome, type 2 | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCA CL E G H | 2175 | 3582 | OMIM:227650 | Fanconi anemia | | | | 340 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCA CL E G H | 2175 | 3582 | ORPHA:84 | Fanconi anemia | | | | 340 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCB CL E G H | 2187 | 3583 | ORPHA:84 | Fanconi anemia | | | | 58 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCB CL E G H | 2187 | 3583 | OMIM:300514 | FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB | | | | 58 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCB CL E G H | 2187 | 3583 | ORPHA:3412 | VACTERL with hydrocephalus | | | | 58 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCC CL E G H | 2176 | 3584 | ORPHA:84 | Fanconi anemia | | | | 410 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCC CL E G H | 2176 | 3584 | OMIM:227645 | Fanconi anemia, complementation group C | | | | 410 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCD2 CL E G H | 2177 | 3585 | ORPHA:84 | Fanconi anemia | | | | 147 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCD2 CL E G H | 2177 | 3585 | OMIM:227646 | Fanconi anemia, complementation group D2 | | | | 147 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCE CL E G H | 2178 | 3586 | ORPHA:84 | Fanconi anemia | | | | 73 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCE CL E G H | 2178 | 3586 | OMIM:600901 | Fanconi anemia, complementation group E | | | | 73 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCF CL E G H | 2188 | 3587 | ORPHA:84 | Fanconi anemia | | | | 87 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCF CL E G H | 2188 | 3587 | OMIM:603467 | FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF | | | | 87 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCG CL E G H | 2189 | 3588 | ORPHA:84 | Fanconi anemia | | | | 73 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCG CL E G H | 2189 | 3588 | OMIM:614082 | FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG | | | | 73 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCI CL E G H | 55215 | 25568 | ORPHA:84 | Fanconi anemia | | | | 157 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCI CL E G H | 55215 | 25568 | OMIM:609053 | Fanconi anemia, complementation group I | | | | 157 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCL CL E G H | 55120 | 20748 | ORPHA:84 | Fanconi anemia | | | | 53 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCL CL E G H | 55120 | 20748 | OMIM:614083 | Fanconi anemia, complementation group L | | | | 53 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FANCM CL E G H | 57697 | 23168 | ORPHA:84 | Fanconi anemia | | | | 107 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FBN1 CL E G H | 2200 | 3603 | OMIM:154700 | Marfan syndrome | | | | 1361 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FBN1 CL E G H | 2200 | 3603 | OMIM:608328 | Weill-Marchesani syndrome 2, dominant | | | | 1361 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FBXW11 CL E G H | 23291 | 13607 | OMIM:618914 | NEURODEVELOPMENTAL, JAW, EYE, AND DIGITAL SYNDROME; NEDJED | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FBXW4 CL E G H | 6468 | 10847 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | 37 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FDFT1 CL E G H | 2222 | 3629 | OMIM:618156 | SQUALENE SYNTHASE DEFICIENCY; SQSD | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FGF3 CL E G H | 2248 | 3681 | ORPHA:2791 | Otodental syndrome | | | | 18 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FGFR1 CL E G H | 2260 | 3688 | OMIM:613001 | Encephalocraniocutaneous lipomatosis | | | | 172 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:2117 | Hartsfield syndrome | | | | 172 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | 172 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FGFRL1 CL E G H | 53834 | 3693 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FH CL E G H | 2271 | 3700 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 301 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FIG4 CL E G H | 9896 | 16873 | ORPHA:3472 | Yunis-Varon syndrome | | | | 111 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKBP6 CL E G H | 8468 | 3722 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKRP CL E G H | 79147 | 17997 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 157 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKRP CL E G H | 79147 | 17997 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 157 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKRP CL E G H | 79147 | 17997 | OMIM:613153 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5 | | | | 157 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKRP CL E G H | 79147 | 17997 | ORPHA:899 | Walker-Warburg syndrome | | | | 157 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKTN CL E G H | 2218 | 3622 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 184 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKTN CL E G H | 2218 | 3622 | OMIM:253800 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4 | | | | 184 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FKTN CL E G H | 2218 | 3622 | ORPHA:899 | Walker-Warburg syndrome | | | | 184 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXA2 CL E G H | 3170 | 5022 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXC1 CL E G H | 2296 | 3800 | OMIM:601631 | Anterior segment dysgenesis 3 | | | | 63 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXC1 CL E G H | 2296 | 3800 | ORPHA:782 | Axenfeld-Rieger syndrome | | | | 63 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXC1 CL E G H | 2296 | 3800 | OMIM:602482 | Axenfeld-rieger syndrome, type 3 | | | | 63 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXC1 CL E G H | 2296 | 3800 | ORPHA:250923 | Isolated aniridia | | | | 63 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXC2 CL E G H | 2303 | 3801 | OMIM:153400 | Lymphedema-Distichiasis syndrome | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXE3 CL E G H | 2301 | 3808 | OMIM:610256 | Anterior segment dysgenesis 2 | | | | 23 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXE3 CL E G H | 2301 | 3808 | ORPHA:83461 | Congenital primary aphakia | | | | 23 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FOXL2 CL E G H | 668 | 1092 | OMIM:110100 | Blepharophimosis, epicanthus inversus, and ptosis | | | | 92 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FRAS1 CL E G H | 80144 | 19185 | ORPHA:2052 | Fraser syndrome | | | | 353 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FRAS1 CL E G H | 80144 | 19185 | OMIM:219000 | Fraser syndrome | | | | 353 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FREM1 CL E G H | 158326 | 23399 | OMIM:248450 | Manitoba oculotrichoanal syndrome | | | | 198 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FREM1 CL E G H | 158326 | 23399 | ORPHA:2717 | Oculotrichoanal syndrome | | | | 198 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FREM2 CL E G H | 341640 | 25396 | OMIM:123570 | Cryptophthalmos, unilateral or bilateral, isolated | | | | 263 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FREM2 CL E G H | 341640 | 25396 | ORPHA:2052 | Fraser syndrome | | | | 263 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FZD4 CL E G H | 8322 | 4042 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 109 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | FZD4 CL E G H | 8322 | 4042 | ORPHA:91495 | Persistent hyperplastic primary vitreous | | | | 109 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GATAD2B CL E G H | 57459 | 30778 | ORPHA:363686 | Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GDF3 CL E G H | 9573 | 4218 | OMIM:613704 | Microphthalmia, isolated 7 | | | | 7 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GDF3 CL E G H | 9573 | 4218 | OMIM:613703 | MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6 | | | | 7 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GDF6 CL E G H | 392255 | 4221 | OMIM:613094 | MICROPHTHALMIA, ISOLATED 4; MCOP4 | | | | 64 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GDF6 CL E G H | 392255 | 4221 | OMIM:613703 | MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6 | | | | 64 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GJA1 CL E G H | 2697 | 4274 | OMIM:164200 | Oculodentodigital dysplasia | | | | 68 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GJA1 CL E G H | 2697 | 4274 | OMIM:257850 | Oculodentodigital dysplasia, autosomal recessive | | | | 68 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GJA5 CL E G H | 2702 | 4279 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GJA8 CL E G H | 2703 | 4281 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 34 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 173 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GLI2 CL E G H | 2736 | 4318 | OMIM:610829 | Holoprosencephaly 9 | | | | 173 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GLI3 CL E G H | 2737 | 4319 | OMIM:146510 | Pallister-Hall syndrome | | | | 270 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GLI3 CL E G H | 2737 | 4319 | ORPHA:672 | Pallister-Hall syndrome | | | | 270 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GLYCTK CL E G H | 132158 | 24247 | OMIM:220120 | D-GLYCERIC ACIDURIA | | | | 6 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GMPPB CL E G H | 29925 | 22932 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 34 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GNAT2 CL E G H | 2780 | 4394 | ORPHA:49382 | Achromatopsia | | | | 19 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GPC3 CL E G H | 2719 | 4451 | ORPHA:654 | Nephroblastoma | | | | 73 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GPR143 CL E G H | 4935 | 20145 | ORPHA:54 | X-linked recessive ocular albinism | | | | 64 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GPR161 CL E G H | 23432 | 23694 | ORPHA:95496 | Pituitary stalk interruption syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GRIA4 CL E G H | 2893 | 4574 | OMIM:617864 | Neurodevelopmental disorder with or without seizures and gait abnormalities | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GRIP1 CL E G H | 23426 | 18708 | ORPHA:2052 | Fraser syndrome | | | | 80 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GTF2E2 CL E G H | 2961 | 4651 | ORPHA:33364 | Trichothiodystrophy | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GTF2H5 CL E G H | 404672 | 21157 | ORPHA:33364 | Trichothiodystrophy | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GTF2H5 CL E G H | 404672 | 21157 | OMIM:616395 | Trichothiodystrophy 3, photosensitive | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GTF2I CL E G H | 2969 | 4659 | ORPHA:904 | Williams syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GTF2IRD1 CL E G H | 9569 | 4661 | ORPHA:904 | Williams syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | GTF2IRD2 CL E G H | 84163 | 30775 | ORPHA:904 | Williams syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | H19 CL E G H | 283120 | 4713 | ORPHA:654 | Nephroblastoma | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HCCS CL E G H | 3052 | 4837 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HCCS CL E G H | 3052 | 4837 | OMIM:309801 | Microphthalmia, syndromic 7 | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HDAC6 CL E G H | 10013 | 14064 | OMIM:300863 | Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HDAC6 CL E G H | 10013 | 14064 | ORPHA:163966 | X-linked dominant chondrodysplasia, Chassaing-Lacombe type | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 21 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:95496 | Pituitary stalk interruption syndrome | | | | 21 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | 21 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HESX1 CL E G H | 8820 | 4877 | OMIM:182230 | Septooptic dysplasia | | | | 21 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HHAT CL E G H | 55733 | 18270 | ORPHA:1422 | Chondrodysplasia-disorder of sex development syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HHAT CL E G H | 55733 | 18270 | OMIM:600092 | Nivelon-Nivelon-Mabille syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HMGB3 CL E G H | 3149 | 5004 | OMIM:300915 | Microphthalmia, syndromic 13 | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HMX1 CL E G H | 3166 | 5017 | OMIM:612109 | Oculoauricular syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HNRNPK CL E G H | 3190 | 5044 | ORPHA:352665 | Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HNRNPK CL E G H | 3190 | 5044 | ORPHA:453504 | Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HNRNPU CL E G H | 3192 | 5048 | ORPHA:238769 | 1q44 microdeletion syndrome | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HPS4 CL E G H | 89781 | 15844 | OMIM:614073 | Hermansky-Pudlak syndrome 4 | | | | 123 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HPS5 CL E G H | 11234 | 17022 | OMIM:614074 | Hermansky-Pudlak syndrome 5 | | | | 105 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HRAS CL E G H | 3265 | 5173 | ORPHA:2612 | Linear nevus sebaceus syndrome | | | | 113 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HS2ST1 CL E G H | 9653 | 5193 | OMIM:619194 | NEUROFACIOSKELETAL SYNDROME WITH OR WITHOUT RENAL AGENESIS; NFSRA | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:800 | Schwartz-Jampel syndrome | HP:0040283 - Occasional | | | 345 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HYLS1 CL E G H | 219844 | 26558 | ORPHA:2189 | Hydrolethalus | | | | 31 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | HYLS1 CL E G H | 219844 | 26558 | OMIM:236680 | Hydrolethalus syndrome 1 | | | | 31 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | IFT74 CL E G H | 80173 | 21424 | OMIM:619582 | JOUBERT SYNDROME 40; JBTS40 | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | IGF1R CL E G H | 3480 | 5465 | OMIM:270450 | Insulin-Like growth factor I, resistance to | | | | 268 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | IKBKG CL E G H | 8517 | 5961 | OMIM:308300 | Incontinentia pigmenti | | | | 52 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | IKBKG CL E G H | 8517 | 5961 | ORPHA:464 | Incontinentia pigmenti | | | | 52 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | INTS1 CL E G H | 26173 | 24555 | OMIM:618571 | NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES; NDCAGF | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | INTU CL E G H | 27152 | 29239 | OMIM:617925 | Short-Rib thoracic dysplasia 20 with polydactyly | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ITPR1 CL E G H | 3708 | 6180 | ORPHA:1065 | Aniridia-cerebellar ataxia-intellectual disability syndrome | | | | 177 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ITPR1 CL E G H | 3708 | 6180 | OMIM:206700 | Gillespie syndrome | | | | 177 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | JAM3 CL E G H | 83700 | 15532 | OMIM:613730 | Hemorrhagic destruction of the brain, subependymal calcification,and cataracts | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KCNK4 CL E G H | 50801 | 6279 | OMIM:618381 | Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KERA CL E G H | 11081 | 6309 | OMIM:217300 | Cornea plana 2 | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KIF11 CL E G H | 3832 | 6388 | OMIM:152950 | Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation | | | | 46 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KIF11 CL E G H | 3832 | 6388 | ORPHA:2526 | Microcephaly-lymphedema-chorioretinopathy syndrome | | | | 46 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KIF14 CL E G H | 9928 | 19181 | OMIM:617914 | Microcephaly 20, primary, autosomal recessive | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KIF15 CL E G H | 56992 | 17273 | OMIM:619981 | | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KIF1B CL E G H | 23095 | 16636 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 202 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KIF7 CL E G H | 374654 | 30497 | ORPHA:2189 | Hydrolethalus | | | | 167 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KNSTRN CL E G H | 90417 | 30767 | ORPHA:221139 | Combined immunodeficiency with faciooculoskeletal anomalies | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | KRAS CL E G H | 3845 | 6407 | ORPHA:2612 | Linear nevus sebaceus syndrome | | | | 196 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LAMB2 CL E G H | 3913 | 6487 | OMIM:609049 | Pierson syndrome | | | | 92 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LARGE1 CL E G H | 9215 | 6511 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 136 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LARGE1 CL E G H | 9215 | 6511 | ORPHA:899 | Walker-Warburg syndrome | | | | 136 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LDHD CL E G H | 197257 | 19708 | OMIM:245450 | LACTIC ACIDURIA DUE TO D-LACTIC ACID | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LETM1 CL E G H | 3954 | 6556 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:95496 | Pituitary stalk interruption syndrome | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LIMK1 CL E G H | 3984 | 6613 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LMBRD2 CL E G H | 92255 | 25287 | OMIM:619694 | DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES; DENBA | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LMX1B CL E G H | 4010 | 6654 | OMIM:161200 | Nail-Patella syndrome | | | | 165 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LRP2 CL E G H | 4036 | 6694 | OMIM:222448 | Donnai-Barrow syndrome | | | | 289 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LRP5 CL E G H | 4041 | 6697 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 125 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LRP5 CL E G H | 4041 | 6697 | OMIM:259770 | Osteoporosis-Pseudoglioma syndrome | | | | 125 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LRP5 CL E G H | 4041 | 6697 | ORPHA:2788 | Osteoporosis-pseudoglioma syndrome | | | | 125 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LTBP2 CL E G H | 4053 | 6715 | OMIM:251750 | Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma | | | | 123 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LTBP2 CL E G H | 4053 | 6715 | OMIM:614819 | Weill-Marchesani syndrome 3 | | | | 123 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | LYST CL E G H | 1130 | 1968 | OMIM:214500 | Chediak-Higashi syndrome | | | | 239 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAB21L2 CL E G H | 10586 | 6758 | OMIM:615877 | Microphthalmia/coloboma and skeletal dysplasia syndrome | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MACF1 CL E G H | 23499 | 13664 | ORPHA:572013 | Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAD2L2 CL E G H | 10459 | 6764 | ORPHA:84 | Fanconi anemia | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAF CL E G H | 4094 | 6776 | OMIM:610202 | Cataract 21, multiple types | | | | 21 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAFB CL E G H | 9935 | 6408 | ORPHA:233 | Duane retraction syndrome | | | | 63 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAP2K2 CL E G H | 5605 | 6842 | OMIM:615280 | Cardiofaciocutaneous syndrome 4 | | | | 178 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAPRE2 CL E G H | 10982 | 6891 | ORPHA:2505 | Multiple benign circumferential skin creases on limbs | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAPRE2 CL E G H | 10982 | 6891 | OMIM:616734 | Skin creases, congenital symmetric circumferential, 2 | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MAX CL E G H | 4149 | 6913 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 84 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:85284 | BRESEK syndrome | | | | 22 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MC1R CL E G H | 4157 | 6929 | OMIM:203200 | Albinism, oculocutaneous, type II | | | | 124 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MC1R CL E G H | 4157 | 6929 | ORPHA:79432 | Oculocutaneous albinism type 2 | | | | 124 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MDH2 CL E G H | 4191 | 6971 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MED12 CL E G H | 9968 | 11957 | ORPHA:93932 | FG syndrome type 1 | | | | 228 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MED12 CL E G H | 9968 | 11957 | OMIM:300895 | Ohdo syndrome, X-linked | | | | 228 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MED13L CL E G H | 23389 | 22962 | ORPHA:369891 | Developmental delay-facial dysmorphism syndrome due to MED13L deficiency | | | | 74 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MED25 CL E G H | 81857 | 28845 | ORPHA:464738 | Basel-Vanagaite-Smirin-Yosef syndrome | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MEF2C CL E G H | 4208 | 6996 | ORPHA:228384 | 5q14.3 microdeletion syndrome | | | | 132 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | METTL27 CL E G H | 155368 | 19068 | ORPHA:904 | Williams syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MFRP CL E G H | 83552 | 18121 | OMIM:611040 | Microphthalmia, isolated 5 | | | | 26 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MFRP CL E G H | 83552 | 18121 | ORPHA:35612 | Nanophthalmos | | | | 26 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MFRP CL E G H | 83552 | 18121 | OMIM:609549 | Nanophthalmos 2 | | | | 26 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MIR184 CL E G H | 406960 | 31555 | OMIM:614303 | Edict syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MITF CL E G H | 4286 | 7105 | OMIM:617306 | Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness | | | | 91 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MITF CL E G H | 4286 | 7105 | OMIM:193510 | Waardenburg syndrome, type 2A | | | | 91 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MKS1 CL E G H | 54903 | 7121 | ORPHA:564 | Meckel syndrome | | | | 127 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MKS1 CL E G H | 54903 | 7121 | OMIM:249000 | Meckel syndrome 1 | | | | 127 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MLXIPL CL E G H | 51085 | 12744 | ORPHA:904 | Williams syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MPDZ CL E G H | 8777 | 7208 | OMIM:615219 | Hydrocephalus, congenital, 2, with or without brain or eye anomalies | | | | 29 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MPLKIP CL E G H | 136647 | 16002 | ORPHA:33364 | Trichothiodystrophy | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MPLKIP CL E G H | 136647 | 16002 | OMIM:234050 | Trichothiodystrophy 4, nonphotosensitive | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MTSS2 CL E G H | 92154 | 25094 | OMIM:620086 | | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | MYO5A CL E G H | 4644 | 7602 | ORPHA:33445 | Neuroectodermal melanolysosomal disease | | | | 35 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NAA10 CL E G H | 8260 | 18704 | ORPHA:568 | Microphthalmia, Lenz type | | | | 23 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NAA10 CL E G H | 8260 | 18704 | OMIM:309800 | Microphthalmia, syndromic 1 | | | | 23 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NCF1 CL E G H | 653361 | 7660 | ORPHA:904 | Williams syndrome | | | | 13 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDE1 CL E G H | 54820 | 17619 | ORPHA:2177 | Hydranencephaly | | | | 96 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDP CL E G H | 4693 | 7678 | ORPHA:190 | Coats disease | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDP CL E G H | 4693 | 7678 | OMIM:305390 | Exudative vitreoretinopathy 2, X-linked | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDP CL E G H | 4693 | 7678 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDP CL E G H | 4693 | 7678 | ORPHA:649 | Norrie disease | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDP CL E G H | 4693 | 7678 | OMIM:310600 | Norrie disease | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDP CL E G H | 4693 | 7678 | ORPHA:91495 | Persistent hyperplastic primary vitreous | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NDUFB11 CL E G H | 54539 | 20372 | OMIM:309801 | Microphthalmia, syndromic 7 | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NEFL CL E G H | 4747 | 7739 | ORPHA:101085 | Charcot-Marie-Tooth disease type 1F | | | | 118 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NEXMIF CL E G H | 340533 | 29433 | ORPHA:1942 | Myoclonic-astatic epilepsy | | | | 52 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NF1 CL E G H | 4763 | 7765 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 1952 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NFIX CL E G H | 4784 | 7788 | ORPHA:420179 | Malan overgrowth syndrome | | | | 40 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NFIX CL E G H | 4784 | 7788 | OMIM:602535 | Marshall-Smith syndrome | | | | 40 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NHS CL E G H | 4810 | 7820 | ORPHA:627 | Nance-Horan syndrome | | | | 88 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NHS CL E G H | 4810 | 7820 | OMIM:302350 | Nance-Horan syndrome | | | | 88 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NOTCH1 CL E G H | 4851 | 7881 | ORPHA:974 | Adams-Oliver syndrome | | | | 452 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NR2F1 CL E G H | 7025 | 7975 | ORPHA:401777 | Optic atrophy-intellectual disability syndrome | | | | 37 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NRAS CL E G H | 4893 | 7989 | ORPHA:2612 | Linear nevus sebaceus syndrome | | | | 102 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NSD2 CL E G H | 7468 | 12766 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 118 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NUAK2 CL E G H | 81788 | 29558 | OMIM:619452 | ANENCEPHALY 2; ANPH2 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | NUP188 CL E G H | 23511 | 17859 | OMIM:618804 | SANDESTIG-STEFANOVA SYNDROME; SANDSTEF | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OCA2 CL E G H | 4948 | 8101 | OMIM:203200 | Albinism, oculocutaneous, type II | | | | 121 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OCA2 CL E G H | 4948 | 8101 | ORPHA:79432 | Oculocutaneous albinism type 2 | | | | 121 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OCRL CL E G H | 4952 | 8108 | OMIM:309000 | Lowe syndrome | | | | 88 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OCRL CL E G H | 4952 | 8108 | ORPHA:534 | Oculocerebrorenal syndrome of Lowe | | | | 88 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OSGEP CL E G H | 55644 | 18028 | OMIM:617729 | Galloway-Mowat syndrome 3 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OTUD5 CL E G H | 55593 | 25402 | OMIM:301056 | MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED; MCAND | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OTX2 CL E G H | 5015 | 8522 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 41 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OTX2 CL E G H | 5015 | 8522 | OMIM:610125 | Microphthalmia, syndromic 5 | | | | 41 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OTX2 CL E G H | 5015 | 8522 | ORPHA:35612 | Nanophthalmos | | | | 41 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | OTX2 CL E G H | 5015 | 8522 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | 41 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PALB2 CL E G H | 79728 | 26144 | ORPHA:84 | Fanconi anemia | | | | 1349 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX2 CL E G H | 5076 | 8616 | OMIM:120330 | Papillorenal syndrome | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX3 CL E G H | 5077 | 8617 | OMIM:193500 | Waardenburg syndrome, type 1 | | | | 59 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | OMIM:106210 | Aniridia | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | ORPHA:1065 | Aniridia-cerebellar ataxia-intellectual disability syndrome | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | OMIM:604229 | Anterior segment dysgenesis 5, multiple subtypes | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | ORPHA:2334 | Autosomal dominant keratitis | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | OMIM:120200 | COLOBOMA, OCULAR, AUTOSOMAL DOMINANT | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | OMIM:136520 | Foveal hypoplasia and presenile cataract syndromefoveal hypoplasia, isolated, included | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | ORPHA:250923 | Isolated aniridia | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | ORPHA:137902 | Isolated optic nerve hypoplasia/aplasia | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | OMIM:165550 | OPTIC NERVE HYPOPLASIA, BILATERAL | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | ORPHA:893 | WAGR syndrome | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PAX6 CL E G H | 5080 | 8620 | OMIM:194072 | Wilms tumor, aniridia, genitourinary anomalies, and mental retardationsyndrome | | | | 194 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PCYT1A CL E G H | 5130 | 8754 | ORPHA:85167 | Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PDE6C CL E G H | 5146 | 8787 | ORPHA:49382 | Achromatopsia | | | | 80 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PDE6D CL E G H | 5147 | 8788 | OMIM:615665 | Joubert syndrome 22 | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PDE6H CL E G H | 5149 | 8790 | ORPHA:49382 | Achromatopsia | | | | 14 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PEX7 CL E G H | 5191 | 8860 | ORPHA:773 | Refsum disease | | | | 72 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PHGDH CL E G H | 26227 | 8923 | OMIM:256520 | Neu-Laxova syndrome | | | | 37 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PHYH CL E G H | 5264 | 8940 | ORPHA:773 | Refsum disease | | | | 45 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PIEZO2 CL E G H | 63895 | 26270 | OMIM:248700 | Marden-Walker syndrome | | | | 77 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PIGN CL E G H | 23556 | 8967 | ORPHA:2059 | Fryns syndrome | | | | 37 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PIK3CA CL E G H | 5290 | 8975 | OMIM:602501 | Megalencephaly-Capillary malformation-polymicrogyria syndrome | | | | 162 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PIK3CD CL E G H | 5293 | 8977 | ORPHA:221139 | Combined immunodeficiency with faciooculoskeletal anomalies | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PIK3R1 CL E G H | 5295 | 8979 | OMIM:269880 | Short syndrome | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PIK3R1 CL E G H | 5295 | 8979 | ORPHA:3163 | SHORT syndrome | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PITX2 CL E G H | 5308 | 9005 | OMIM:137600 | ANTERIOR SEGMENT DYSGENESIS 4; ASGD4 | | | | 51 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PITX2 CL E G H | 5308 | 9005 | ORPHA:782 | Axenfeld-Rieger syndrome | | | | 51 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PITX2 CL E G H | 5308 | 9005 | OMIM:180500 | Axenfeld-rieger syndrome, type 1 | | | | 51 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PITX3 CL E G H | 5309 | 9006 | OMIM:610623 | Cataract 11, multiple types | | | | 6 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PLK4 CL E G H | 10733 | 11397 | OMIM:616171 | Microcephaly and chorioretinopathy, autosomal recessive, 2 | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PLXNA1 CL E G H | 5361 | 9099 | OMIM:619955 | | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POGZ CL E G H | 23126 | 18801 | OMIM:616364 | White-Sutton syndrome | | | | 35 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POLR1B CL E G H | 84172 | 20454 | ORPHA:861 | Treacher-Collins syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POLR1C CL E G H | 9533 | 20194 | ORPHA:861 | Treacher-Collins syndrome | | | | 38 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POLR1D CL E G H | 51082 | 20422 | ORPHA:861 | Treacher-Collins syndrome | | | | 31 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 180 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMGNT1 CL E G H | 55624 | 19139 | OMIM:253280 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3 | | | | 180 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:899 | Walker-Warburg syndrome | | | | 180 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMGNT2 CL E G H | 84892 | 25902 | OMIM:614830 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8 | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMGNT2 CL E G H | 84892 | 25902 | ORPHA:899 | Walker-Warburg syndrome | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMK CL E G H | 84197 | 26267 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 18 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMK CL E G H | 84197 | 26267 | OMIM:615249 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12 | | | | 18 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMK CL E G H | 84197 | 26267 | ORPHA:899 | Walker-Warburg syndrome | | | | 18 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMT1 CL E G H | 10585 | 9202 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 213 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMT1 CL E G H | 10585 | 9202 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 213 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMT1 CL E G H | 10585 | 9202 | ORPHA:899 | Walker-Warburg syndrome | | | | 213 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMT2 CL E G H | 29954 | 19743 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 221 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMT2 CL E G H | 29954 | 19743 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 221 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMT2 CL E G H | 29954 | 19743 | OMIM:613150 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2 | | | | 221 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POMT2 CL E G H | 29954 | 19743 | ORPHA:899 | Walker-Warburg syndrome | | | | 221 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PORCN CL E G H | 64840 | 17652 | ORPHA:2092 | Focal dermal hypoplasia | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PORCN CL E G H | 64840 | 17652 | OMIM:305600 | Focal dermal hypoplasia | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 36 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | POU6F2 CL E G H | 11281 | 21694 | ORPHA:654 | Nephroblastoma | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PPP1CB CL E G H | 5500 | 9282 | OMIM:617506 | Noonan syndrome-like disorder with loose anagen hair 2 | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PPP2R1A CL E G H | 5518 | 9302 | ORPHA:457284 | Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome | | | | 13 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PQBP1 CL E G H | 10084 | 9330 | OMIM:309500 | Renpenning syndrome | | | | 28 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PRIM1 CL E G H | 5557 | 9369 | OMIM:620005 | | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PROKR2 CL E G H | 128674 | 15836 | ORPHA:95496 | Pituitary stalk interruption syndrome | | | | 34 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PROKR2 CL E G H | 128674 | 15836 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | 34 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PROM1 CL E G H | 8842 | 9454 | ORPHA:827 | Stargardt disease | | | | 110 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 54 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PRPH2 CL E G H | 5961 | 9942 | ORPHA:827 | Stargardt disease | | | | 159 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:423479 | X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome | | | | 49 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PRR12 CL E G H | 57479 | 29217 | OMIM:619539 | NEUROOCULAR SYNDROME; NOC | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PRSS56 CL E G H | 646960 | 39433 | OMIM:613517 | Microphthalmia, isolated 6 | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PRSS56 CL E G H | 646960 | 39433 | ORPHA:35612 | Nanophthalmos | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PTCH1 CL E G H | 5727 | 9585 | OMIM:109400 | Basal cell nevus syndrome | | | | 665 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PTCH1 CL E G H | 5727 | 9585 | OMIM:610828 | Holoprosencephaly 7 | | | | 665 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:77301 | Monosomy 9q22.3 | | | | 665 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PTCH2 CL E G H | 8643 | 9586 | OMIM:109400 | Basal cell nevus syndrome | | | | 40 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PTF1A CL E G H | 256297 | 23734 | OMIM:609069 | Pancreatic and cerebellar agenesis | | | | 22 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PTF1A CL E G H | 256297 | 23734 | ORPHA:65288 | Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome | | | | 22 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PTPN23 CL E G H | 25930 | 14406 | OMIM:618890 | NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY; NEDBASS | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PUF60 CL E G H | 22827 | 17042 | ORPHA:508488 | 8q24.3 microdeletion syndrome | | | | 19 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | PUF60 CL E G H | 22827 | 17042 | ORPHA:508498 | Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome | | | | 19 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAB18 CL E G H | 22931 | 14244 | ORPHA:2510 | Micro syndrome | | | | 85 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAB18 CL E G H | 22931 | 14244 | OMIM:614222 | Warburg micro syndrome 3 | | | | 85 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAB3GAP1 CL E G H | 22930 | 17063 | ORPHA:2510 | Micro syndrome | | | | 90 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAB3GAP1 CL E G H | 22930 | 17063 | OMIM:600118 | Warburg micro syndrome 1 | | | | 90 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAB3GAP2 CL E G H | 25782 | 17168 | OMIM:212720 | Martsolf syndrome 1 | | | | 135 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAB3GAP2 CL E G H | 25782 | 17168 | ORPHA:2510 | Micro syndrome | | | | 135 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAB3GAP2 CL E G H | 25782 | 17168 | OMIM:614225 | Warburg micro syndrome 2 | | | | 135 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAD51 CL E G H | 5888 | 9817 | ORPHA:84 | Fanconi anemia | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAD51C CL E G H | 5889 | 9820 | ORPHA:84 | Fanconi anemia | | | | 391 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RARB CL E G H | 5915 | 9865 | ORPHA:2470 | Matthew-Wood syndrome | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RARB CL E G H | 5915 | 9865 | OMIM:615524 | Microphthalmia, syndromic 12 | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAX CL E G H | 30062 | 18662 | OMIM:611038 | Microphthalmia, isolated 3 | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RAX CL E G H | 30062 | 18662 | ORPHA:35612 | Nanophthalmos | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RB1 CL E G H | 5925 | 9884 | ORPHA:1587 | Monosomy 13q14 | | | | 365 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RBBP8 CL E G H | 5932 | 9891 | OMIM:606744 | Seckel syndrome 2 | | | | 68 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RBP4 CL E G H | 5950 | 9922 | OMIM:616428 | Microphthalmia, isolated, with coloboma 10 | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RBPJ CL E G H | 3516 | 5724 | ORPHA:974 | Adams-Oliver syndrome | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RECQL4 CL E G H | 9401 | 9949 | OMIM:268400 | ROTHMUND-THOMSON SYNDROME; RTS | | | | 445 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RERE CL E G H | 473 | 9965 | OMIM:616975 | Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart | | | | 16 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RERE CL E G H | 473 | 9965 | ORPHA:494344 | RERE-related neurodevelopmental syndrome | | | | 16 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | REST CL E G H | 5978 | 9966 | ORPHA:654 | Nephroblastoma | | | | 7 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RET CL E G H | 5979 | 9967 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 572 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RFC2 CL E G H | 5982 | 9970 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RFWD3 CL E G H | 55159 | 25539 | ORPHA:84 | Fanconi anemia | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RHOA CL E G H | 387 | 667 | OMIM:618727 | ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES; EDFAOB | | | | 8 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RIPK4 CL E G H | 54101 | 496 | OMIM:263650 | Popliteal pterygium syndrome, Bartsocas-Papas type 1 | | | | 69 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RMRP CL E G H | 6023 | 10031 | ORPHA:175 | Cartilage-hair hypoplasia | HP:0040283 - Occasional | | | 37 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RNF113A CL E G H | 7737 | 12974 | ORPHA:33364 | Trichothiodystrophy | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RNF113A CL E G H | 7737 | 12974 | OMIM:300953 | Trichothiodystrophy 5, nonphotosensitive | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RNF135 CL E G H | 84282 | 21158 | ORPHA:137634 | Overgrowth-macrocephaly-facial dysmorphism syndrome | | | | 11 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ROBO1 CL E G H | 6091 | 10249 | ORPHA:95496 | Pituitary stalk interruption syndrome | | | | 7 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RPGR CL E G H | 6103 | 10295 | ORPHA:49382 | Achromatopsia | | | | 200 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RPGRIP1 CL E G H | 57096 | 13436 | ORPHA:564 | Meckel syndrome | | | | 109 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RPGRIP1L CL E G H | 23322 | 29168 | ORPHA:564 | Meckel syndrome | | | | 167 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RPGRIP1L CL E G H | 23322 | 29168 | OMIM:611561 | Meckel syndrome, type 5 | | | | 167 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RSPO2 CL E G H | 340419 | 28583 | ORPHA:3301 | Tetraamelia-multiple malformations syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RTTN CL E G H | 25914 | 18654 | ORPHA:468631 | Microcephalic cortical malformations-short stature due to RTTN deficiency | | | | 113 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RTTN CL E G H | 25914 | 18654 | OMIM:614833 | Microcephaly, short stature, and polymicrogyria with or without seizures | | | | 113 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | RXYLT1 CL E G H | 10329 | 13530 | ORPHA:899 | Walker-Warburg syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SALL1 CL E G H | 6299 | 10524 | ORPHA:857 | Townes-Brocks syndrome | | | | 124 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SALL4 CL E G H | 57167 | 15924 | ORPHA:959 | Acro-renal-ocular syndrome | | | | 86 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SALL4 CL E G H | 57167 | 15924 | ORPHA:233 | Duane retraction syndrome | | | | 86 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SALL4 CL E G H | 57167 | 15924 | OMIM:607323 | Duane-Radial ray syndrome | | | | 86 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SCN1A CL E G H | 6323 | 10585 | ORPHA:1942 | Myoclonic-astatic epilepsy | | | | 1053 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SCN8A CL E G H | 6334 | 10596 | OMIM:614306 | Cognitive impairment with or without cerebellar ataxia | | | | 357 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SDHA CL E G H | 6389 | 10680 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 304 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SDHAF2 CL E G H | 54949 | 26034 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 55 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SDHB CL E G H | 6390 | 10681 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 237 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SDHC CL E G H | 6391 | 10682 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 147 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SDHD CL E G H | 6392 | 10683 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 129 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SEM1 CL E G H | 7979 | 10845 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SEMA3E CL E G H | 9723 | 10727 | ORPHA:138 | CHARGE syndrome | | | | 16 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SETD5 CL E G H | 55209 | 25566 | ORPHA:404440 | Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency | | | | 43 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SF3B2 CL E G H | 10992 | 10769 | OMIM:164210 | Hemifacial microsomia | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SHH CL E G H | 6469 | 10848 | OMIM:611638 | Microphthalmia, isolated, with coloboma 5 | | | | 67 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SHH CL E G H | 6469 | 10848 | OMIM:147250 | Solitary median maxillary central incisor | | | | 67 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SIN3A CL E G H | 25942 | 19353 | OMIM:613406 | Witteveen-Kolk syndrome | | | | 9 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SIX3 CL E G H | 6496 | 10889 | OMIM:157170 | Holoprosencephaly 2 | | | | 32 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SIX6 CL E G H | 4990 | 10892 | OMIM:206900 | Microphthalmia, syndromic 3 | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SIX6 CL E G H | 4990 | 10892 | ORPHA:35612 | Nanophthalmos | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SIX6 CL E G H | 4990 | 10892 | OMIM:212550 | Optic disc anomalies with retinal and/or macular dystrophy | | | | 20 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC24A5 CL E G H | 283652 | 20611 | OMIM:113750 | Albinism, oculocutaneous, type VI | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC24A5 CL E G H | 283652 | 20611 | ORPHA:370097 | Oculocutaneous albinism type 6 | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC25A11 CL E G H | 8402 | 10981 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC25A24 CL E G H | 29957 | 20662 | OMIM:612289 | Fontaine progeroid syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:1942 | Myoclonic-astatic epilepsy | | | | 255 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC38A8 CL E G H | 146167 | 32434 | OMIM:609218 | Foveal hypoplasia 2 | | | | 13 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC45A2 CL E G H | 51151 | 16472 | OMIM:606574 | ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4 | | | | 42 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC45A2 CL E G H | 51151 | 16472 | ORPHA:79435 | Oculocutaneous albinism type 4 | | | | 42 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLC6A1 CL E G H | 6529 | 11042 | ORPHA:1942 | Myoclonic-astatic epilepsy | | | | 29 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SLX4 CL E G H | 84464 | 23845 | ORPHA:84 | Fanconi anemia | | | | 274 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMAD4 CL E G H | 4089 | 6770 | OMIM:139210 | Myhre syndrome | | | | 504 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMARCA2 CL E G H | 6595 | 11098 | ORPHA:2728 | Blepharophimosis-intellectual disability syndrome, Ohdo type | | | | 146 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMCHD1 CL E G H | 23347 | 29090 | OMIM:603457 | Bosma arhinia microphthalmia syndrome | | | | 174 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMCHD1 CL E G H | 23347 | 29090 | ORPHA:2250 | Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome | | | | 174 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMG9 CL E G H | 56006 | 25763 | OMIM:616920 | Heart and brain malformation syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:1553 | Curry-Jones syndrome | | | | 22 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMO CL E G H | 6608 | 11119 | OMIM:601707 | Curry-Jones syndrome | | | | 22 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMOC1 CL E G H | 64093 | 20318 | ORPHA:1106 | Microphthalmia with limb anomalies | | | | 15 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SMOC1 CL E G H | 64093 | 20318 | OMIM:206920 | Microphthalmia with limb anomalies | | | | 15 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SNAP29 CL E G H | 9342 | 11133 | OMIM:609528 | Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome | | | | 94 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SON CL E G H | 6651 | 11183 | ORPHA:500150 | Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SOX10 CL E G H | 6663 | 11190 | OMIM:611584 | Waardenburg syndrome, type 2E | | | | 61 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SOX2 CL E G H | 6657 | 11195 | ORPHA:77298 | Anophthalmia/microphthalmia-esophageal atresia syndrome | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SOX2 CL E G H | 6657 | 11195 | OMIM:206900 | Microphthalmia, syndromic 3 | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SOX2 CL E G H | 6657 | 11195 | ORPHA:35612 | Nanophthalmos | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SOX2 CL E G H | 6657 | 11195 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SOX3 CL E G H | 6658 | 11199 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | 24 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SPECC1L CL E G H | 23384 | 29022 | OMIM:600251 | Facial clefting, oblique, 1 | | | | 6 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SPOP CL E G H | 8405 | 11254 | OMIM:618828 | NABAIS SA-DE VRIES SYNDROME, TYPE 1; NSDVS1 | | | | 16 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SRD5A3 CL E G H | 79644 | 25812 | OMIM:612379 | Congenital disorder of glycosylation, type IQ | | | | 80 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SRD5A3 CL E G H | 79644 | 25812 | ORPHA:324737 | SRD5A3-CDG | | | | 80 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | STAG2 CL E G H | 10735 | 11355 | OMIM:301043 | HOLOPROSENCEPHALY 13, X-LINKED; HPE13 | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | STIM1 CL E G H | 6786 | 11386 | OMIM:612783 | Immunodeficiency 10 | | | | 31 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | STRA6 CL E G H | 64220 | 30650 | ORPHA:2470 | Matthew-Wood syndrome | | | | 71 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | STRA6 CL E G H | 64220 | 30650 | OMIM:601186 | Microphthalmia, syndromic 9 | | | | 71 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | STX1A CL E G H | 6804 | 11433 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SUFU CL E G H | 51684 | 16466 | OMIM:109400 | Basal cell nevus syndrome | | | | 124 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SYCE1 CL E G H | 93426 | 28852 | OMIM:616947 | PREMATURE OVARIAN FAILURE 12; POF12 | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | SYNGAP1 CL E G H | 8831 | 11497 | ORPHA:1942 | Myoclonic-astatic epilepsy | | | | 108 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TARS1 CL E G H | 6897 | 11572 | ORPHA:33364 | Trichothiodystrophy | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBC1D20 CL E G H | 128637 | 16133 | ORPHA:2510 | Micro syndrome | | | | 15 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBC1D20 CL E G H | 128637 | 16133 | OMIM:615663 | Warburg micro syndrome 4 | | | | 15 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBCE CL E G H | 6905 | 11582 | ORPHA:2323 | Sanjad-Sakati syndrome | HP:0040283 - Occasional | | | 52 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBL1XR1 CL E G H | 79718 | 29529 | OMIM:602342 | Pierpont syndrome | | | | 22 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:487825 | Pierpont syndrome | | | | 22 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBL2 CL E G H | 26608 | 11586 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBR1 CL E G H | 10716 | 11590 | ORPHA:1617 | 2q24 microdeletion syndrome | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 32 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TBX15 CL E G H | 6913 | 11594 | OMIM:260660 | Cousin syndrome | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TCOF1 CL E G H | 6949 | 11654 | OMIM:154500 | Treacher collins-franceschetti syndrome | | | | 140 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TCOF1 CL E G H | 6949 | 11654 | ORPHA:861 | Treacher-Collins syndrome | | | | 140 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TCTN1 CL E G H | 79600 | 26113 | ORPHA:564 | Meckel syndrome | | | | 45 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TCTN2 CL E G H | 79867 | 25774 | ORPHA:564 | Meckel syndrome | | | | 76 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TCTN2 CL E G H | 79867 | 25774 | OMIM:613885 | Meckel syndrome, type 8 | | | | 76 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TCTN3 CL E G H | 26123 | 24519 | ORPHA:564 | Meckel syndrome | | | | 31 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TENM3 CL E G H | 55714 | 29944 | OMIM:615145 | Microphthalmia, isolated, with coloboma 9 | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TFAP2A CL E G H | 7020 | 11742 | OMIM:113620 | Branchiooculofacial syndrome | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TKFC CL E G H | 26007 | 24552 | OMIM:618805 | TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME; TKFCD | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM107 CL E G H | 84314 | 28128 | ORPHA:564 | Meckel syndrome | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM127 CL E G H | 55654 | 26038 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 131 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM216 CL E G H | 51259 | 25018 | OMIM:608091 | Joubert syndrome 2 | | | | 45 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM216 CL E G H | 51259 | 25018 | ORPHA:564 | Meckel syndrome | | | | 45 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM216 CL E G H | 51259 | 25018 | OMIM:603194 | Meckel syndrome, type 2 | | | | 45 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM231 CL E G H | 79583 | 37234 | ORPHA:564 | Meckel syndrome | | | | 33 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM237 CL E G H | 65062 | 14432 | OMIM:614424 | Joubert syndrome 14 | | | | 82 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:564 | Meckel syndrome | | | | 82 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM270 CL E G H | 135886 | 23018 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM67 CL E G H | 91147 | 28396 | ORPHA:564 | Meckel syndrome | | | | 166 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM98 CL E G H | 26022 | 24529 | ORPHA:35612 | Nanophthalmos | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMEM98 CL E G H | 26022 | 24529 | OMIM:615972 | Nanophthalmos 4 | | | | 3 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TMTC3 CL E G H | 160418 | 26899 | OMIM:617255 | Lissencephaly 8 | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TOGARAM1 CL E G H | 23116 | 19959 | OMIM:619185 | JOUBERT SYNDROME 37; JBTS37 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TONSL CL E G H | 4796 | 7801 | ORPHA:93357 | SPONASTRIME dysplasia | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TP63 CL E G H | 8626 | 15979 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | 140 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TRIM28 CL E G H | 10155 | 16384 | ORPHA:654 | Nephroblastoma | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TRIM44 CL E G H | 54765 | 19016 | ORPHA:250923 | Isolated aniridia | | | | 1 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TRIP13 CL E G H | 9319 | 12307 | ORPHA:1052 | Mosaic variegated aneuploidy syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TRIP13 CL E G H | 9319 | 12307 | ORPHA:654 | Nephroblastoma | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TRIT1 CL E G H | 54802 | 20286 | OMIM:617873 | Combined oxidative phosphorylation deficiency 35 | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TSPAN12 CL E G H | 23554 | 21641 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBA1A CL E G H | 7846 | 20766 | ORPHA:171680 | Lissencephaly due to TUBA1A mutation | | | | 106 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBA8 CL E G H | 51807 | 12410 | ORPHA:250972 | Polymicrogyria with optic nerve hypoplasia | | | | 21 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBB CL E G H | 203068 | 20778 | OMIM:615771 | Cortical dysplasia, complex, with other brain malformations 6 | | | | 14 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBB CL E G H | 203068 | 20778 | ORPHA:2505 | Multiple benign circumferential skin creases on limbs | | | | 14 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBB CL E G H | 203068 | 20778 | OMIM:156610 | Skin creases, congenital symmetric circumferential, 1 | | | | 14 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBB3 CL E G H | 10381 | 20772 | ORPHA:300570 | Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation | | | | 64 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBGCP4 CL E G H | 27229 | 16691 | OMIM:616335 | Microcephaly and chorioretinopathy, autosomal recessive, 3 | | | | 14 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TUBGCP6 CL E G H | 85378 | 18127 | OMIM:251270 | Microcephaly and chorioretinopathy, autosomal recessive, 1 | | | | 61 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TXNDC15 CL E G H | 79770 | 20652 | OMIM:619879 | | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TXNDC15 CL E G H | 79770 | 20652 | ORPHA:564 | Meckel syndrome | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TYR CL E G H | 7299 | 12442 | OMIM:203100 | Albinism, oculocutaneous, type IA | | | | 146 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TYR CL E G H | 7299 | 12442 | ORPHA:79431 | Oculocutaneous albinism type 1A | | | | 146 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | TYR CL E G H | 7299 | 12442 | ORPHA:79434 | Oculocutaneous albinism type 1B | | | | 146 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | UBE2T CL E G H | 29089 | 25009 | ORPHA:84 | Fanconi anemia | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | UGP2 CL E G H | 7360 | 12527 | OMIM:618744 | DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83; DEE83 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VAC14 CL E G H | 55697 | 25507 | ORPHA:3472 | Yunis-Varon syndrome | | | | 6 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VAX1 CL E G H | 11023 | 12660 | OMIM:614402 | Microphthalmia, syndromic 11 | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VHL CL E G H | 7428 | 12687 | ORPHA:29072 | Hereditary pheochromocytoma-paraganglioma | | | | 490 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VPS13B CL E G H | 157680 | 2183 | ORPHA:193 | Cohen syndrome | | | | 546 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VPS35L CL E G H | 57020 | 24641 | OMIM:619135 | RITSCHER-SCHINZEL SYNDROME 3; RTSC3 | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VPS37D CL E G H | 155382 | 18287 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VSX1 CL E G H | 30813 | 12723 | OMIM:614195 | Craniofacial anomalies and anterior segment dysgenesis syndrome | | | | 47 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VSX2 CL E G H | 338917 | 1975 | OMIM:610093 | MICROPHTHALMIA, ISOLATED 2; MCOP2 | | | | 66 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | VSX2 CL E G H | 338917 | 1975 | OMIM:610092 | MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3 | | | | 66 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WDR11 CL E G H | 55717 | 13831 | ORPHA:95496 | Pituitary stalk interruption syndrome | | | | 10 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WDR37 CL E G H | 22884 | 31406 | OMIM:618652 | NEUROOCULOCARDIOGENITOURINARY SYNDROME; NOCGUS | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WDR73 CL E G H | 84942 | 25928 | OMIM:251300 | Galloway-mowat syndrome 1 | | | | 14 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WNT10B CL E G H | 7480 | 12775 | ORPHA:2440 | Isolated split hand-split foot malformation | | | | 4 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WNT3 CL E G H | 7473 | 12782 | OMIM:273395 | Tetraamelia, autosomal recessive | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WNT3 CL E G H | 7473 | 12782 | ORPHA:3301 | Tetraamelia-multiple malformations syndrome | | | | 12 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WT1 CL E G H | 7490 | 12796 | OMIM:106210 | Aniridia | | | | 177 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WT1 CL E G H | 7490 | 12796 | ORPHA:654 | Nephroblastoma | | | | 177 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WT1 CL E G H | 7490 | 12796 | ORPHA:893 | WAGR syndrome | | | | 177 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | WT1 CL E G H | 7490 | 12796 | OMIM:194072 | Wilms tumor, aniridia, genitourinary anomalies, and mental retardationsyndrome | | | | 177 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | XRCC2 CL E G H | 7516 | 12829 | ORPHA:84 | Fanconi anemia | | | | 125 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | XYLT2 CL E G H | 64132 | 15517 | ORPHA:85194 | Spondylo-ocular syndrome | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | YAP1 CL E G H | 10413 | 16262 | OMIM:120433 | Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | YAP1 CL E G H | 10413 | 16262 | ORPHA:1473 | Uveal coloboma-cleft lip and palate-intellectual disability | | | | 2 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ZEB2 CL E G H | 9839 | 14881 | OMIM:235730 | Mowat-Wilson syndrome | | | | 362 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ZEB2 CL E G H | 9839 | 14881 | ORPHA:261552 | Mowat-Wilson syndrome due to a ZEB2 point mutation | | | | 362 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ZEB2 CL E G H | 9839 | 14881 | ORPHA:261537 | Mowat-Wilson syndrome due to monosomy 2q22 | | | | 362 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ZIC1 CL E G H | 7545 | 12872 | OMIM:618736 | STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS; BAIDCS | | | | 5 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ZNF408 CL E G H | 79797 | 20041 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 14 | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ZNF699 CL E G H | 374879 | 24750 | OMIM:619488 | DEGCAGS SYNDROME; DEGCAGS | | | | | | |
HP:0008056 | HP:0008056 | Aplasia/Hypoplasia affecting the eye | 0 | ZPR1 CL E G H | 8882 | 13051 | OMIM:619321 | GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF | | | | | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ABCA4 CL E G H | 24 | 34 | ORPHA:827 | Stargardt disease | | | | 826 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ABCB6 CL E G H | 10058 | 47 | OMIM:614497 | Microphthalmia, isolated, with coloboma 7 | HP:0040283 - Occasional | | | 20 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ACTB CL E G H | 60 | 132 | OMIM:243310 | Baraitser-Winter syndrome 1 | HP:0040283 - Occasional | | | 72 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ACTG1 CL E G H | 71 | 144 | OMIM:614583 | Baraitser-Winter syndrome 2 | HP:0040283 - Occasional | | | 123 | | |
HP:0008056 | HP:0008062 | Aplasia/Hypoplasia affecting the anterior segment of the eye | 1 | ADAMTS10 CL E G H | 81794 | 13201 | OMIM:277600 | Weill-Marchesani syndrome 1 | | | | 63 | | |
HP:0008056 | HP:0008055 | Aplasia/Hypoplasia affecting the uvea | 1 | ADAMTSL1 CL E G H | 92949 | 14632 | ORPHA:521445 | Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome | | | | | | |
HP:0008056 | HP:0008062 | Aplasia/Hypoplasia affecting the anterior segment of the eye | 1 | ADAMTSL1 CL E G H | 92949 | 14632 | ORPHA:521445 | Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome | | | | | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ALDH1A2 CL E G H | 8854 | 15472 | OMIM:620025 | | | | | | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ALDH1A3 CL E G H | 220 | 409 | OMIM:615113 | Microphthalmia, isolated 8 | | | | 10 | | |
HP:0008056 | HP:0000528 | Anophthalmia | 1 | ALDH1A3 CL E G H | 220 | 409 | OMIM:615113 | Microphthalmia, isolated 8 | | | | 10 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALDH1A3 CL E G H | 220 | 409 | OMIM:615113 | Microphthalmia, isolated 8 | . | | | 10 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALDH1A3 CL E G H | 220 | 409 | ORPHA:35612 | Nanophthalmos | HP:0040281 - Very frequent | | | 10 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALDH6A1 CL E G H | 4329 | 7179 | OMIM:614105 | Methylmalonate semialdehyde dehydrogenase deficiency | . | | | 35 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALX1 CL E G H | 8092 | 1494 | OMIM:613456 | Frontonasal dysplasia 3 | . | | | 5 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALX1 CL E G H | 8092 | 1494 | ORPHA:306542 | Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome | HP:0040282 - Frequent | | | 5 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALX3 CL E G H | 257 | 449 | OMIM:136760 | Frontonasal dysplasia 1 | . | | | 9 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALX3 CL E G H | 257 | 449 | ORPHA:391474 | Frontorhiny | HP:0040282 - Frequent | | | 9 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALX4 CL E G H | 60529 | 450 | OMIM:613451 | Frontonasal dysplasia 2 | | | | 132 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ALX4 CL E G H | 60529 | 450 | ORPHA:228390 | Frontonasal dysplasia-alopecia-genital anomalies syndrome | HP:0040282 - Frequent | | | 132 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ANKRD11 CL E G H | 29123 | 21316 | ORPHA:261250 | 16q24.3 microdeletion syndrome | | | | 102 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | AP2M1 CL E G H | 1173 | 564 | ORPHA:1942 | Myoclonic-astatic epilepsy | HP:0040284 - Very rare | | | | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | AP3D1 CL E G H | 8943 | 568 | ORPHA:54 | X-linked recessive ocular albinism | | | | 1 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | APC CL E G H | 324 | 583 | ORPHA:261584 | Familial adenomatous polyposis due to 5q22.2 microdeletion | | | | 3179 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ARHGAP31 CL E G H | 57514 | 29216 | ORPHA:974 | Adams-Oliver syndrome | HP:0040282 - Frequent | | | 147 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ARHGAP31 CL E G H | 57514 | 29216 | OMIM:100300 | Adams-Oliver syndrome 1 | . | | | 147 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ARNT2 CL E G H | 9915 | 16876 | ORPHA:3157 | Septo-optic dysplasia spectrum | | | | | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ARSL CL E G H | 415 | 719 | ORPHA:79345 | Brachytelephalangic chondrodysplasia punctata | | | | | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ARX CL E G H | 170302 | 18060 | OMIM:308350 | Developmental and epileptic encephalopathy 1 | | | | 166 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ASPH CL E G H | 444 | 757 | OMIM:601552 | Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs | HP:0040283 - Occasional | | | 4 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ATAD3A CL E G H | 55210 | 25567 | ORPHA:496790 | Ocular anomalies-axonal neuropathy-developmental delay syndrome | | | | 5 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ATF6 CL E G H | 22926 | 791 | ORPHA:49382 | Achromatopsia | | | | 10 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ATF6 CL E G H | 22926 | 791 | OMIM:616517 | ACHROMATOPSIA 7; ACHM7 | | | | 10 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ATN1 CL E G H | 1822 | 3033 | OMIM:618494 | Congenital hypotonia, epilepsy, developmental delay, and digital anomalies | | | | 16 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ATOH7 CL E G H | 220202 | 13907 | ORPHA:91495 | Persistent hyperplastic primary vitreous | | | | 4 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | ATOH7 CL E G H | 220202 | 13907 | ORPHA:91495 | Persistent hyperplastic primary vitreous | | | | 4 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | ATOH7 CL E G H | 220202 | 13907 | OMIM:221900 | Persistent hyperplastic primary vitreous, autosomal recessive | . | | | 4 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | B3GALNT2 CL E G H | 148789 | 28596 | OMIM:615181 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 | . | | | 43 | | |
HP:0008056 | HP:0008057 | Aplasia/Hypoplasia affecting the fundus | 1 | B3GALNT2 CL E G H | 148789 | 28596 | OMIM:615181 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 | | | | 43 | | |
HP:0008056 | HP:0000528 | Anophthalmia | 1 | B3GALNT2 CL E G H | 148789 | 28596 | ORPHA:899 | Walker-Warburg syndrome | HP:0040282 - Frequent | | | 43 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | B3GALNT2 CL E G H | 148789 | 28596 | ORPHA:899 | Walker-Warburg syndrome | HP:0040282 - Frequent | | | 43 | | |
HP:0008056 | HP:0000528 | Anophthalmia | 1 | B4GAT1 CL E G H | 11041 | 15685 | ORPHA:899 | Walker-Warburg syndrome | HP:0040282 - Frequent | | | 17 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | B4GAT1 CL E G H | 11041 | 15685 | ORPHA:899 | Walker-Warburg syndrome | HP:0040282 - Frequent | | | 17 | | |
HP:0008056 | HP:0008062 | Aplasia/Hypoplasia affecting the anterior segment of the eye | 1 | B9D1 CL E G H | 27077 | 24123 | ORPHA:564 | Meckel syndrome | | | | 28 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | B9D1 CL E G H | 27077 | 24123 | ORPHA:564 | Meckel syndrome | HP:0040282 - Frequent | | | 28 | | |
HP:0008056 | HP:0008055 | Aplasia/Hypoplasia affecting the uvea | 1 | B9D1 CL E G H | 27077 | 24123 | ORPHA:564 | Meckel syndrome | | | | 28 | | |
HP:0008056 | HP:0000528 | Anophthalmia | 1 | B9D1 CL E G H | 27077 | 24123 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 28 | | |
HP:0008056 | HP:0000528 | Anophthalmia | 1 | B9D2 CL E G H | 80776 | 28636 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 34 | | |
HP:0008056 | HP:0008055 | Aplasia/Hypoplasia affecting the uvea | 1 | B9D2 CL E G H | 80776 | 28636 | ORPHA:564 | Meckel syndrome | | | | 34 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | B9D2 CL E G H | 80776 | 28636 | ORPHA:564 | Meckel syndrome | HP:0040282 - Frequent | | | 34 | | |
HP:0008056 | HP:0008062 | Aplasia/Hypoplasia affecting the anterior segment of the eye | 1 | B9D2 CL E G H | 80776 | 28636 | ORPHA:564 | Meckel syndrome | | | | 34 | | |
HP:0008056 | HP:0008062 | Aplasia/Hypoplasia affecting the anterior segment of the eye | 1 | BAZ1B CL E G H | 9031 | 961 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008055 | Aplasia/Hypoplasia affecting the uvea | 1 | BAZ1B CL E G H | 9031 | 961 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008062 | Aplasia/Hypoplasia affecting the anterior segment of the eye | 1 | BCL7B CL E G H | 9275 | 1005 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0008055 | Aplasia/Hypoplasia affecting the uvea | 1 | BCL7B CL E G H | 9275 | 1005 | ORPHA:904 | Williams syndrome | | | | | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | BCOR CL E G H | 54880 | 20893 | ORPHA:568 | Microphthalmia, Lenz type | HP:0040281 - Very frequent | | | 101 | | |
HP:0008056 | HP:0000528 | Anophthalmia | 1 | BCOR CL E G H | 54880 | 20893 | OMIM:309800 | Microphthalmia, syndromic 1 | | | | 101 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | BCOR CL E G H | 54880 | 20893 | OMIM:309800 | Microphthalmia, syndromic 1 | . | | | 101 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | BCOR CL E G H | 54880 | 20893 | OMIM:300166 | Microphthalmia, syndromic 2 | | | | 101 | | |
HP:0008056 | HP:0000528 | Anophthalmia | 1 | BCOR CL E G H | 54880 | 20893 | OMIM:300166 | Microphthalmia, syndromic 2 | . | | | 101 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | BCOR CL E G H | 54880 | 20893 | ORPHA:2712 | Oculofaciocardiodental syndrome | HP:0040281 - Very frequent | | | 101 | | |
HP:0008056 | HP:0008055 | Aplasia/Hypoplasia affecting the uvea | 1 | BDNF CL E G H | 627 | 1033 | ORPHA:893 | WAGR syndrome | | | | 5 | | |
HP:0008056 | HP:0008062 | Aplasia/Hypoplasia affecting the anterior segment of the eye | 1 | BDNF CL E G H | 627 | 1033 | ORPHA:893 | WAGR syndrome | | | | 5 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | BEST1 CL E G H | 7439 | 12703 | ORPHA:35612 | Nanophthalmos | HP:0040281 - Very frequent | | | 182 | | |
HP:0008056 | HP:0000568 | Microphthalmia | 1 | BEST1 CL E |